Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Senior Research Scientist in the Center for Genomics and Systems Biology (CGSB) – Dr. Claude Desplan
tools for the control of the red palm weevil. For this purpose, experience with CRISPR/Cas9, genomic and molecular techniques is very important. NYUAD offers a stimulating research environment, a
-
Natural Killer cell biology assays, both in vitro and in vivo in xenogeneic models (70% of effort) CRISPR editing of tumor cell lines and primary NK cells will be necessary to assess for the project
-
employs cutting-edge technologies, including single-cell genomics, integrated CRISPR screens with single-cell readouts, and highly multiplexed imaging. We work with patient-derived cancer tissue, cell line
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
challenges to global public health. Learn more about MET and their research here: https://www.hsph.harvard.edu/molecular-metabolism/. The lab of Dr. Nora Kory studies compartmentalization of metabolism and
-
positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999 . The interviews will start in April/May 2026. For more information about AMBER, application and evaluation
-
induced pluripotent stem cells (iPSCs); differentiation of pluripotent cells into neuronal lineages; genome engineering using CRISPR/Cas9; molecular biology and biochemistry laboratory techniques (e.g
-
, University of Pennsylvania. Our lab specializes in therapeutic gene editing, with a specific focus on using next-generation CRISPR tools for in vivo gene editing to address cardiovascular, metabolic, and other
-
, University of Pennsylvania. Our lab specializes in therapeutic gene editing, with a specific focus on using next-generation CRISPR tools for in vivo gene editing to address cardiovascular, metabolic, and other